Leucadia Therapeutics
neurons-PG8PZMF.jpg

Story

Understanding the Problem

Currently, there are no effective treatments for Alzheimer's disease that slow or halt the relentless progression of this devastating disorder.   

Imagine a life where you don't recognize your loved ones and can't talk to them, where you can't take care of yourself and you slowly lose hold of faculties that make you the person you are.  These are realities for patients afflicted with Alzheimer's disease. 

Early in Alzheimer's disease, patients have trouble making new memories, but older memories remain intact. A patient might be able to tell you about a school play that she was in 50 years ago, but can't remember what she had for breakfast.  As the disease progresses, even older memories fade as they can't remember the good times they enjoyed with their parents, their children, grandchildren or friends. Even major life events such as the birth of their children, their careers, their wedding day... gone forever.  Imagine not remembering when you first met your spouse, or when you saw your children walk for the first time. Cherished memories such as these make life worth living and they are stolen by Alzheimer's disease.  

 

Follow Up

Leucadia Therapeutics has a novel approach to defeating AD

Get in touch with us ▸


CONSIDER THE NUMBERS 

Recent studies have shown the following facts and figures.

There are over 35 million people in the world who are plagued with AD. Experts project that there will be more than 100 million people affected by AD by 2050 worldwide.  

There are over 35 million people in the world who are plagued with AD. Experts project that there will be more than 100 million people affected by AD by 2050 worldwide.  

About one third of seniors have dementia by the time they die. 

About one third of seniors have dementia by the time they die

More than 250M people alive today will develop Alzheimer’s disease between now and 2050 (worldwide).

More than 250M people alive today will develop Alzheimer’s disease between now and 2050 (worldwide).

In the past 20 years, Alzheimer’s has risen from the 25th most burdensome disease in the US to the 12th. No other disease or condition increased as much.

In the past 20 years, Alzheimer’s has risen from the 25th most burdensome disease in the US to the 12th. No other disease or condition increased as much.

The estimated yearly healthcare cost for the healthcare patients with Alzheimer’s or other dementias worldwide is 818 billion dollars.

The estimated yearly healthcare cost for the healthcare patients with Alzheimer’s or other dementias worldwide is 818 billion dollars.

The projected total annual cost to care for people with Alzheimer’s and other dementias by 2018 is 1 trillion dollars.

The projected total annual cost to care for people with Alzheimer’s and other dementias by 2018 is 1 trillion dollars.

Of the caregivers who provide help to older adults, 46% do so for someone with Alzheimer’s or another dementia.

Of the caregivers who provide help to older adults, 46% do so for someone with Alzheimer’s or another dementia.

30 to 40 percent of family caregivers of people with dementia suffer from depression, compared with 5 to 17 percent of similar populations.

30 to 40 percent of family caregivers of people with dementia suffer from depression, compared with 5 to 17 percent of similar populations.

Every 3.2 seconds someone worldwide develops Alzheimer’s or another dementia.

Every 3.2 seconds someone worldwide develops Alzheimer’s or another dementia.